The study group had significant reductions in DAS 28 scores ( 3.39 versus 4.99 in control group ) and significantly more subjects achieved the ACR 20/50/70 criteria at the end of 3 months ( 100/60/36 % versus 84/20/0 % ) Secondary end-points like tender and swollen joint count , ESR , early morning stiffness , health assessment questionnaire ( HAQ ) scores and general health status were significantly reduced in the study group .